Latest News

Thanks to a $10 million donation, Cabrini Health, in partnership with Monash University, is aiming to transform cancer care for Victorians.

The Federal Government has released the final report of the Health Technology Assessment (HTA) Review, marking the first comprehensive review of Australia’s HTA system in nearly 30 years.

Vaxxas has initiated a multi-centre Phase 1 clinical trial of a vaccine against pre-pandemic avian influenza strain H7N9, using its high-density microarray patch.

Telix (ASX:TLX) has announced that the primary results from its Phase 3 ZIRCON trial have been published in The Lancet Oncology.

CUREator, Australia's national biotech incubator managed by Brandon BioCatalyst, has announced that four companies will receive top-up funding across its Preclinical and Health Security streams. 

Dimerix (ASX:DXB) has announced that the first patient has completed the ACTION3 Phase 3 clinical trial, including the initial follow-up period, and has chosen to enter the global open-label extension study.

AusBiotech is pleased to announce the appointment of Tamlyn O’Connor as its new Industry Growth Program Manager.

Dimerix (ASX:DXB) has announced that the first patient has completed the ACTION3 Phase 3 clinical trial, including the initial follow-up period, and has chosen to enter the global open-label extension study.

Nyrada (ASX:NYR) has provided an update on the development of its brain injury program with investigative first-in-class neuroprotection treatment, NYR-BI03.

Biotron (ASX:BIT) has provided an update on the BIT225-012 Phase 2 clinical trial of its lead antiviral drug BIT225 for treating COVID-19.

Australian clinical-stage biopharmaceutical company ENA Respiratory has been awarded an additional US$3.18 million contract from the US Department of Defense.

AusBiotech was pleased to be invited to participate in a HealthTech Roundtable and Business Luncheon with the Hong Kong Government’s Financial Secretary, Mr Paul Chan, and members to discuss growth opportunities for Australian biotech in Hong Kong and Asia.